HMPV: What is it?
The well-known Respiratory Syncytial Virus (RSV) is a member of the Pneumoviridae family, which also contains the 2001-discovered Human Metapneumovirus (HMPV). Studies have revealed that HMPV has been present in humans for more than 60 years and is present all across the world, even though it was just formally recognized in 2001. Although people of all ages can get upper and lower respiratory illnesses from the virus, those with compromised immune systems, elderly people, and small children are more susceptible.
The signs and dangers of HMPV
Coughing, fever, congestion of the nose, and shortness of breath are all symptoms of HMPV that are similar to those of other respiratory diseases.
But according to recent research, the virus has been connected to an increase in unexpected fatalities, especially among those between the ages of 40 and 80. As a result, China's healthcare system is under more strain, with overcrowded hospitals and a surge in pneumonia cases, particularly among youngsters.
According to one social media post: "Chinese hospitals and crematoriums are being overrun by several viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19. Rising pneumonia and "white lung" infections are especially taxing children's hospitals.
An increase in cases
The positive incidence of HMPV in children under 14 has been rising and fluctuating recently, according to a study released by the Chinese Center for Disease Control and Prevention (CDC) in late December. China's national broadcaster CCTV reports that the increase in HMPV cases has raised serious concerns, particularly given how quickly the virus is spreading throughout the country.
HMPV is spread by respiratory droplets, person-to-person contact (such as handshakes), and contact with contaminated items, according to Li Tongzeng, a top physician at beijing You'an Hospital. The virus takes three to five days to incubate.
How to avoid
Experts suggest a few simple yet efficient strategies to stop HMPV from spreading. These include increasing immunity, cleaning hands often, and using masks. Avoiding close contact with sick people is also essential to lowering the chance of transmission.
Experts advise avoiding treating HMPV with antiviral medications, despite the rising concern. A respiratory specialist at a hospital in shanghai claims that there is no vaccine for HMPV and that the illness's symptoms are similar to those of the common cold. The specialist cautioned the public that antiviral medications may not work against this virus if they are used without the right advice.
HMPV's global expansion
Although HMPV was initially discovered in China, the virus has subsequently spread to a number of other nations. Its global reach and potential to create significant health issues were highlighted in 2023 when it was discovered in the US, China, the Netherlands, the UK, Finland, Australia, and Canada.